US Surgical extends supply deal and offer for Circon:
This article was originally published in Clinica
Executive Summary
US Surgical has extended its agreements with University HealthSystem Consortium for sutures, disposable staplers and laparoscopic instruments until June 2000. The extended contracts are expected to result in an additional $68 million for the US company. In a separate development, US Surgical has extended its hostile takeover offer for Circon until July 16. The price remains the same at $16.50 per share. US Surgical made its initial offer for Circon in August 1996 (see Clinica No 718, p 9).
You may also be interested in...
Boehringer Ingelheim Overtakes Bayer As Germany’s Biggest Pharma Company
The privately-owned company is searching for a successor to Jardiance, while the outcome of US Inflation Reduction Act talks on price cuts to the blockbuster will be revealed in September.
Synthekine Joins Quest To Tame IL-2 In Cancer Therapies
First clinical data from Synthekine’s IL-2 candidate and that ofrivalsMedicennawere presented at the AACR, suggesting there’s life in the modality yet.
Swisse Supplements Take Bigger Slice Of Chinese Market
Australian-heritage Swisse grew its share of China's supplements market in 2023 by delivering tailored products to an increasingly health conscious population.